{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:05:43Z","timestamp":1747181143636,"version":"3.40.5"},"reference-count":68,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"26","license":[{"start":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T00:00:00Z","timestamp":1656547200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>Severe acute respiratory syndrome (SARS) caused by a novel coronavirus-2 (CoV-2), also known as COVID-19, has spread rapidly worldwide since it is recognized as a public health emergency and has now been declared a pandemic on March 11, 2020, by the World Health Organization.<\/jats:p>\n          <jats:p>The genome of SARS-CoV-2 comprises a single-stranded positive-sense RNA approximately 27 to 30\u2009kb in size. The virus is transmitted through droplets from humans to humans. Infection with the SARS virus varies from asymptomatic to lethal, such as fever, cough, sore throat, and headache, but in severe cases, pneumonia and acute respiratory distress syndrome.<\/jats:p>\n          <jats:p>Recently, no specific and effective treatment has been recommended for patients infected with the SARS virus. However, several options can be investigated to control SARS-CoV-2 infection, including monoclonal antibodies, interferons, therapeutic vaccines, and molecular-based targeted drugs.<\/jats:p>\n          <jats:p>In the current review, we focus on tyrosine kinase inhibitor management and their protective role in SARS-CoV-2 patients with chronic myelogenous leukemia.<\/jats:p>","DOI":"10.1097\/md.0000000000029660","type":"journal-article","created":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T12:05:19Z","timestamp":1656590719000},"page":"e29660","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Role of tyrosine kinase inhibitor in chronic myeloid leukemia patients with SARS-CoV-2 infection: A narrative Review"],"prefix":"10.1097","volume":"101","author":[{"given":"Muhammad","family":"Asif","sequence":"first","affiliation":[{"name":"Department of Biotechnology, BUITEMS, Quetta, Pakistan"},{"name":"Office of Research Innovation and Commercialization, BUITEMS, Quetta, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Amir","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, BUITEMS, Quetta, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abrar","family":"Hussain","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, BUITEMS, Quetta, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8872-6046","authenticated-orcid":false,"given":"Niaz M.","family":"Achakzai","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology, City Medical Complex, Kabul, Afghanistan"},{"name":"Department of Molecular Biology, DNA section, Legal Medicine Directorate, Ministry of Public Health, Kabul, Afghanistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Natesan Pushparaj","sequence":"additional","affiliation":[{"name":"Center of Excellence in Genomic Medicine Research, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia"},{"name":"Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2997-5891","authenticated-orcid":false,"given":"Mahmood","family":"Rasool","sequence":"additional","affiliation":[{"name":"Center of Excellence in Genomic Medicine Research, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia"},{"name":"Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,6,30]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.tim.2016.03.003","article-title":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses.","volume":"24","author":"Su","year":"2016","journal-title":"Trends Microbiol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1038\/nm1143","article-title":"Severe acute respiratory syndrome.","volume":"10","author":"Peiris","year":"2004","journal-title":"Nat Med"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1046\/j.1440-1843.2003.00518.x","article-title":"SARS: epidemiology.","volume":"8","author":"Chan-Yeung","year":"2003","journal-title":"Respirology"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1056\/NEJMoa1211721","article-title":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia.","volume":"367","author":"Zaki","year":"2012","journal-title":"N Engl J Med"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.3390\/jcm9041225","article-title":"The COVID-19 pandemic: a comprehensive review of taxonomy, genetics, epidemiology, diagnosis, treatment, and control.","volume":"9","author":"Helmy","year":"2020","journal-title":"J Clin Med"},{"key":"R7-20250504","first-page":"e00187","article-title":"Emergence of a novel coronavirus, severe acute respiratory syndrome coronavirus 2: biology and therapeutic options.","volume":"58","author":"Khan","year":"2020","journal-title":"J Clin Microbiol"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1056\/NEJMoa2001316","article-title":"Early transmission dynamics in Wuhan, China, of novel coronavirus\u2013infected pneumonia.","volume":"382","author":"Li","year":"2020","journal-title":"N Engl J Med"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(20)30154-9","article-title":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster.","volume":"395","author":"Chan","year":"2020","journal-title":"Lancet"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"R11-20250504","first-page":"1","article-title":"2019 novel coronavirus (COVID-19) outbreak: a review of the current literature.","volume":"4","author":"Sahin","year":"2020","journal-title":"EJMO"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/trstmh\/traa025","article-title":"COVID-19: a fast evolving pandemic.","volume":"114","author":"Whitworth","year":"2020","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41579-018-0118-9","article-title":"Origin and evolution of pathogenic coronaviruses.","volume":"17","author":"Cui","year":"2019","journal-title":"Nat Rev Microbiol"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/s41564-020-0695-z","article-title":"The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2.","volume":"5","author":"of the International","year":"2020","journal-title":"Nat Microbiol"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1128\/MMBR.69.4.635-664.2005","article-title":"Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus.","volume":"69","author":"Weiss","year":"2005","journal-title":"Microbiol Mol Biol Rev"},{"key":"R17-20250504","first-page":"1305","article-title":"Coronaviridae.","volume":"2007","author":"Lai","year":"1318","journal-title":"Fields Virology"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijsu.2020.02.034","article-title":"World Health Organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19).","volume":"76","author":"Sohrabi","year":"2020","journal-title":"Int J Surg"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"104327","DOI":"10.1016\/j.meegid.2020.104327","article-title":"Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2)-an update on the status.","volume":"83","author":"Abd El-Aziz","year":"2020","journal-title":"Infect Genet Evol"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/jmv.25700","article-title":"Genomic variance of the 2019-nCoV coronavirus.","volume":"92","author":"Ceraolo","year":"2020","journal-title":"J Med Virol"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1126\/science.1116480","article-title":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor.","volume":"309","author":"Li","year":"2005","journal-title":"Science"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"104351","DOI":"10.1016\/j.meegid.2020.104351","article-title":"Emergence of genomic diversity and recurrent mutations in SARS-CoV-2.","volume":"83","author":"van Dorp","year":"2020","journal-title":"Infect Genet Evol"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12098-020-03263-6","article-title":"A review of coronavirus disease-2019 (COVID-19).","volume":"87","author":"Singhal","year":"2020","journal-title":"Indian J Pediatr"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1093\/bib\/bbx108","article-title":"MAFFT online service: multiple sequence alignment, interactive sequence choice and visualization.","volume":"20","author":"Katoh","year":"2017","journal-title":"Brief Bioinform"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/molbev\/msy096","article-title":"MEGA X: molecular evolutionary genetics analysis across computing platforms.","volume":"35","author":"Kumar","year":"2018","journal-title":"Mol Biol Evol"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor.","volume":"581","author":"Lan","year":"2020","journal-title":"Nature"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein.","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation.","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.it.2020.02.007","article-title":"SARS coronavirus redux.","volume":"41","author":"Qing","year":"2020","journal-title":"Trends Immunol"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"e7870","DOI":"10.1371\/journal.pone.0007870","article-title":"Cleavage of the SARS coronavirus spike glycoprotein by airway proteases enhances virus entry into human bronchial epithelial cells in vitro.","volume":"4","author":"Kam","year":"2009","journal-title":"PLoS One"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"8887","DOI":"10.1128\/JVI.00415-08","article-title":"Cathepsin L functionally cleaves the severe acute respiratory syndrome coronavirus class I fusion protein upstream of rather than adjacent to the fusion peptide.","volume":"82","author":"Bosch","year":"2008","journal-title":"J Virol"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"11985","DOI":"10.1128\/JVI.01412-08","article-title":"Entry from the cell surface of severe acute respiratory syndrome coronavirus with cleaved S protein as revealed by pseudotype virus bearing cleaved S protein.","volume":"82","author":"Watanabe","year":"2008","journal-title":"J Virol"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.3390\/v4061011","article-title":"Mechanisms of coronavirus cell entry mediated by the viral spike protein.","volume":"4","author":"Belouzard","year":"2012","journal-title":"Viruses"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1056\/NEJMc2001468","article-title":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany.","volume":"382","author":"Rothe","year":"2020","journal-title":"N Engl J Med"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ijid.2020.01.009","article-title":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health\u2014The latest 2019 novel coronavirus outbreak in Wuhan, China.","volume":"91","author":"Hui","year":"2020","journal-title":"Int J Infect Dis"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/jmv.25689","article-title":"Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China.","volume":"92","author":"Wang","year":"2020","journal-title":"J Med Virol"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1001\/jama.2020.2565","article-title":"Presumed asymptomatic carrier transmission of COVID-19.","volume":"323","author":"Bai","year":"2020","journal-title":"JAMA"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.coi.2019.12.002","article-title":"Recent human genetic errors of innate immunity leading to increased susceptibility to infection.","volume":"62","author":"Moens","year":"2020","journal-title":"Curr Opin Immunol"},{"key":"R41-20250504","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1056\/NEJMcibr1917242","article-title":"Activating immunity to fight a foe\u2014a new path.","volume":"382","author":"Hotchkiss","year":"2020","journal-title":"N Engl J Med"},{"key":"R42-20250504","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome.","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir Med"},{"key":"R43-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41565-020-0732-3","article-title":"Immune-mediated approaches against COVID-19.","volume":"15","author":"Florindo","year":"2020","journal-title":"Nat Nanotechnol"},{"key":"R44-20250504","first-page":"4","article-title":"A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version).","volume":"7","author":"Jin","year":"2020","journal-title":"Mil Med Res"},{"key":"R45-20250504","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S2468-1253(20)30080-7","article-title":"Prevention of SARS-CoV-2 infection in patients with decompensated cirrhosis.","volume":"5","author":"Xiao","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R46-20250504","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/jmv.25749","article-title":"The transmission and diagnosis of 2019 novel coronavirus infection disease (COVID-19): a Chinese perspective.","volume":"92","author":"Han","year":"2020","journal-title":"J Med Virol"},{"key":"R47-20250504","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3343\/alm.2020.40.5.351","article-title":"Guidelines for laboratory diagnosis of coronavirus disease 2019 (COVID-19) in Korea.","volume":"40","author":"Hong","year":"2020","journal-title":"Ann Lab Med"},{"key":"R48-20250504","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.2174\/1568026620999200517043137","article-title":"Novel drugs targeting the SARS-CoV-2\/COVID-19 machinery.","volume":"20","author":"Sternberg","year":"2020","journal-title":"Curr Top Med Chem"},{"key":"R49-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12519-020-00345-5","article-title":"Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus.","volume":"16","author":"Chen","year":"2020","journal-title":"World J Pediatr"},{"key":"R50-20250504","first-page":"170","article-title":"Potential antiviral therapeutics for 2019 Novel Coronavirus.","volume":"43","author":"Li","year":"2020","journal-title":"Zhonghua jie he he hu xi za zhi"},{"key":"R51-20250504","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1021\/acscentsci.0c00272","article-title":"Research and development on therapeutic agents and vaccines for COVID-19 and related human coronavirus diseases.","volume":"6","author":"Liu","year":"2020","journal-title":"ACS Cent Sci"},{"key":"R52-20250504","doi-asserted-by":"crossref","first-page":"6141","DOI":"10.3390\/ijms20246141","article-title":"Mechanisms of disease progression and resistance to tyrosine kinase inhibitor therapy in chronic myeloid leukemia: an update.","volume":"20","author":"Bavaro","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R53-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.17.00186","article-title":"Not so typical: development of atypical chronic myeloid leukemia in a patient with chronic myeloid leukemia.","volume":"1","author":"Saba","year":"2017","journal-title":"JCO Precis Oncol"},{"key":"R54-20250504","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1016\/j.humpath.2013.02.021","article-title":"A novel 5-way translocation t (9; 11; 13; 19; 22) in a case of chronic-phase chronic myeloid leukemia.","volume":"44","author":"Vaidya","year":"2013","journal-title":"Hum Pathol"},{"key":"R55-20250504","doi-asserted-by":"crossref","first-page":"797","DOI":"10.3892\/ol_00000139","article-title":"A rare chronic myeloid leukemia case with Philadelphia chromosome, BCR-ABL e13a3 transcript and complex translocation involving four different chromosomes.","volume":"1","author":"Al Achkar","year":"2010","journal-title":"Oncol Lett"},{"key":"R56-20250504","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.3389\/fonc.2019.01132","article-title":"Management of chronic myeloid leukemia in advanced phase.","volume":"9","author":"Bonifacio","year":"2019","journal-title":"Front Oncol"},{"key":"R57-20250504","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1182\/asheducation-2007.1.371","article-title":"Medical management of CML.","volume":"2007","author":"Shah","year":"2007","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"R58-20250504","first-page":"1","article-title":"Treating Leukemia in the Time of COVID-19.","volume":"143","author":"Paul","year":"2020","journal-title":"Acta Haematol"},{"key":"R59-20250504","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.3389\/fonc.2020.01267","article-title":"Screening strategies for COVID-19 in patients with hematologic malignancies.","volume":"10","author":"Assi","year":"2020","journal-title":"Front Oncol"},{"key":"R60-20250504","doi-asserted-by":"crossref","first-page":"101","DOI":"10.7150\/ijms.1.101","article-title":"Tyrosine kinase\u2013role and significance in cancer.","volume":"1","author":"Paul","year":"2004","journal-title":"Int J Med Sci"},{"key":"R61-20250504","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/med.1022","article-title":"Tyrosine kinase inhibitors: from rational design to clinical trials.","volume":"21","author":"Traxler","year":"2001","journal-title":"Med Res Rev"},{"key":"R62-20250504","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00277-015-2322-2","article-title":"A review of the European LeukemiaNet recommendations for the management of CML.","volume":"94","author":"Baccarani","year":"2015","journal-title":"Ann Hematol"},{"key":"R63-20250504","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrd.2015.37","article-title":"Coronaviruses\u2014drug discovery and therapeutic options.","volume":"15","author":"Zumla","year":"2016","journal-title":"Nat Rev Drug Discovery"},{"key":"R64-20250504","doi-asserted-by":"crossref","first-page":"108409","DOI":"10.1016\/j.clim.2020.108409","article-title":"Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic.","volume":"215","author":"Gasmi","year":"2020","journal-title":"Clin Immunol"},{"key":"R66-20250504","doi-asserted-by":"crossref","first-page":"e20191009","DOI":"10.1084\/jem.20191009","article-title":"Tyrosine kinase inhibitor imatinib augments tumor immunity by depleting effector regulatory T cells.","volume":"217","author":"Tanaka","year":"2020","journal-title":"J Exp Med"},{"key":"R67-20250504","doi-asserted-by":"crossref","first-page":"106273","DOI":"10.1016\/j.leukres.2019.106273","article-title":"Role of cancer immunology in chronic myelogenous leukemia.","volume":"88","author":"Ureshino","year":"2020","journal-title":"Leuk Res"},{"key":"R68-20250504","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.3389\/fphar.2019.01232","article-title":"Immunomodulatory activity of tyrosine kinase inhibitors to elicit cytotoxicity against cancer and viral infection.","volume":"10","author":"Climent","year":"2019","journal-title":"Front Pharmacol"},{"key":"R69-20250504","doi-asserted-by":"crossref","first-page":"8924","DOI":"10.1128\/JVI.01429-16","article-title":"Abelson kinase inhibitors are potent inhibitors of severe acute respiratory syndrome coronavirus and Middle East respiratory syndrome coronavirus fusion.","volume":"90","author":"Coleman","year":"2016","journal-title":"J Virol"},{"key":"R70-20250504","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.1128\/AAC.03036-14","article-title":"Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection.","volume":"58","author":"Dyall","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"R71-20250504","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1099\/jgv.0.001047","article-title":"Coronavirus S protein-induced fusion is blocked prior to hemifusion by Abl kinase inhibitors.","volume":"99","author":"Sisk","year":"2018","journal-title":"J Gen Virol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000029660","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:09:47Z","timestamp":1746331787000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000029660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,30]]},"references-count":68,"journal-issue":{"issue":"26","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000029660","relation":{},"ISSN":["1536-5964"],"issn-type":[{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2022,6,30]]}}}